Chicago Capital Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-185,781
Closed -$4.61M 38
2023
Q3
$4.61M Buy
+185,781
New +$2.1M 12.16% 3

Chicago Capital Management's ICPT Position: Q4 2023 in Review

Chicago Capital Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 185,781 shares — an estimated $4.61M sold.

Chicago Capital Management first reported a position in ICPT in Q3 2023 and held it in 1 quarter. The position peaked at $4.61M in Q3 2023. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

  • Chicago Capital Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
  • Chicago Capital Management sold 185,781 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $4.61M.
  • Chicago Capital Management first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2023 and held it in 1 quarter.
  • Chicago Capital Management's Intercept Pharmaceuticals, Inc. position peaked at $4.61M in Q3 2023.
  • 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on Chicago Capital Management's 13F filing for Q4 2023, filed 13 Feb 2024.